Skip to content

Hear the toughest audience before launch does.

Access and reimbursement stakeholder insight ahead of launch - pricing sensitivities, evidence gaps, objection surfacing.

Book a demoSame platform, same guarantee. Only the scenario changes.
The problem

Why access insight arrives too late

  • Payer advisors are the hardest panel to schedule - so access questions get asked late, thinly, or not at all.
  • In a live room, payers hold back: candid pricing and evidence objections rarely surface in front of a company audience.
  • The objections you didn’t surface pre-launch become the ones that stall reimbursement after it.
How Rumi runs it

One platform. This scenario.

  1. Async access to busy advisors

    Payer and access stakeholders contribute in their own time - the panel you actually want, not the one you could schedule.

  2. Candour by design

    Structured, moderated questioning - with independent input where needed - surfaces the objections a live room suppresses.

  3. Evidence-gap readout

    Pricing sensitivities, evidence gaps and objections organised into a record the launch and access teams can act on.

Why Rumi wins here

The fair-voice mechanics, hardest audience

The same design that hears quiet clinicians hears candid payers - considered written input beats on-the-spot diplomacy.

Full-panel access insight, guaranteed

Every named access stakeholder engages - guaranteed - so the readout covers the whole map.

Expands the buying centre

Commercially adjacent insight that brings market access and commercial teams into the same platform medical affairs runs.

In production with global pharma
AstraZenecaBayerPharmingAmgenNovartisRecordati Rare DiseasesSobiMenarini
The guarantee travels

100% participation is as binding here as on an advisory board.

Same monitoring, same moderator tools, same written terms: a defined panel, a defined bar for participation, and a remedy if we miss.

Payer & market-access panels: your questions

What is a payer advisory board?

A structured engagement with payers, reimbursement and access stakeholders to surface pricing sensitivities, evidence expectations and objections ahead of launch. On Rumi it runs asynchronously in a moderated room, so hard-to-schedule access advisors contribute fully and candidly, on the record.

Why run payer panels asynchronously?

Payer advisors are among the hardest participants to convene live, and the least likely to be fully candid in a room. Asynchronous, structured questioning gets considered written input from the full panel - including the objections that live formats suppress.

See every voice heard, in full, on your own use case.

Book a demo
Thirty minutes with Steve Royle, founder, on your use case.